Inmune Bio Inc (INMB)
Sector • Healthcare Industry • Biotechnology & Pharmaceuticals |
Industry • Biotechnology & Pharmaceuticals |
Sector • Healthcare |
News
Inmune Bio Inc Plummets with A Whopping -56% Revenue Drop in Q3 2023
A shortfall of $-0.36 per Share at the Inmune Bio Inc in the April to June 30 2023 fiscal period
Inmune Bio Inc Faces Significant Challenges: Q1 2023 Earnings Recap Reveals Major Downturn
Very noticeable Reduction in Revenues at the company in the October to December 31 2022 span